Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 Apr 12;13(12):5491–5504. doi: 10.1007/s12652-021-03181-1

EDAS method for decision support modeling under the Pythagorean probabilistic hesitant fuzzy aggregation information

Bushra Batool 1,, Shougi Suliman Abosuliman 2, Saleem Abdullah 3, Shahzaib Ashraf 4
PMCID: PMC8039808  PMID: 33868508

Abstract

The significance of emergency decision-making (EmDM) has been experienced recently due to the continuous occurrence of various emergency situations that have caused significant social and monetary misfortunes. EmDM assumes a manageable role when it is important to moderate property and live misfortunes and to reduce the negative effects on the social and natural turn of events. Genuine world EmDM issues are usually described as complex, time-consuming, lack of data, and the effect of mental practices that make it a challenging task for decision-makers. This article shows the need to manage the various types of vulnerabilities and to monitor practices to resolve these concerns. In clinical analysis, how to select an ideal drug from certain drugs with efficacy values for coronavirus disease has become a common problem these days. To address this issue, we are establishing a multi-attribute decision-making approach (MADMap) based on the EDAS method under Pythagorean probabilistic hesitant fuzzy information. In addition, an algorithm is developed to address the uncertainty in the selection of drugs in EmDM issues with regards to clinical analysis. The actual contextual analysis of the selection of the appropriate drug to treat coronavirus ailment is utilized to show the practicality of our proposed technique. Finally, with the help of a comparative analysis of the TOPSIS technique, we demonstrate the efficiency and applicability of the established methodology.

Keywords: Pythagorean probabilistic hesitant fuzzy set, Decision making

Introduction

In the twenty-first century, with the quick monetary globalization growth and the acceleration of industrialization, ecological issues, diagnostic decision-making is definitely not a basic undertaking in drugs. The proposal and approval of diagnosis must consider the patient’s clinical boundaries, the clinical framework, and the specialist’s clinical information. Specialists utilize more than one million snippets of data in the care of their patients (Pauker et al. 1976) and just about 33% of their time is devoured recording and ordering data (Lunin and Hersh 1995) . Obviously, specialists might be not able to review each thing of related data and to relate every one of these things to the consideration method (Peleg and Tu 2006) . Clinical decision support systems have been established to recuperate quiet insurance and care methodology (Balas et al. 2000; Sittig et al. 2008; Ashraf and Abdullah 2020; Ashraf et al. 2020) established the emergency decision making using fuzzy decision making technique. Various examinations and investigations have uncovered these tools to be effective (Garg et al. 2005; Kawamoto et al. 2005; Kucher et al. 2005; Roshanov et al. 2011) in the fields of diagnosis and treatment.

We discourse the problem of the diagnosis with obtaining adequate and precise data for authentic decision-making because of the ambiguity and imprecision. Zadeh (1965) established fuzzy sets (FSs) which are one of the greatest significant paths for handling the vagueness in multi-attribute decision-making approach. FSs have a drawback that it only deliberates a positive membership grade. Atanassov (1986) established the intuitionistic fuzzy sets (IFSs) by overcoming the drawback of FSs. He deliberated both positive and negative membership grades with the limitation that sum of positive and negative membership grade is fewer than or equal to one. Xu (2007) proposed intuitionistic fuzzy arithmetic aggregation operators. Khan et al. (2019a, b, c) proposed the notion of generalized intuitionistic fuzzy soft sets and discussed their applications in decision making. Xu and Yager (2006) proposed intuitionistic fuzzy geometric aggregation operators. These operators also used to solve multi-attribute decision-making approach under IF information.

Yager (2013, 2013a) established the Pythagorean fuzzy sets (PyFSs) as an enhanced form of IFSs, with the limitation that the square total of the positive and negative grades of membership is fewer than or equivalent to one. For instance, in a situation where the positive membership value is 0.8 and the negative membership value is 0.3, we can’t utilize IFSs because of total of their membership values surpasses one. Consequently, in this circumstance we use PyFSs to bargain the decision-making issues. As a consequence, PyFSs are stronger than IFSs to make a settlement of vagueness in everyday existence issues. Peng and Yang (2015) established the Pythagorean fuzzy aggregation operators. Khan et al. (2019a, b, c) developed the Pythagorean fuzzy Dombi aggregation information. Ashraf et al. (2021) presented the decision making modeling based on sine trigonometric Pythagorean fuzzy information and discussed their applicability in decision making.

To overwhelm the hesitancy, Torra (2010) recognized the notion of FSs with hesitancy. By means of hesitant fuzzy set (HFS), many writers determined problems by aggregating the operators in group decision-making (Liu and Sun 2013; Xia and Xu 2011; Yu et al. 2011; Zhang 2013). Khan et al. (2020) discussed the applications of probabilistic hesitant fuzzy rough set in decision aid system. Afterwards, Liao and Xu (2014) recognized the ideas of HFHAA operator, HFHAG operator, quasi-HFHAA operator, and quasi-HFHAG operator, and recognized some of their properties. Liao and Xu (2015) recognized generalized form of hesitant fuzzy hybrid weighted averaging operator, generalized form of hesitant fuzzy hybrid weighted geometric operator, generalized form of quasi-hesitant fuzzy hybrid weighted averaging operator, generalized form of quasi-hesitant fuzzy hybrid weighted geometric. Khan et al. (2017) recognized the idea of Pythagorean HFS (PyHFS). They presented assessment method and recognized operators to aggregate the data. Khan et al. (2018; 2019a, b, c) recognized Pythagorean hesitant fuzzy weighted average and hybrid aggregation operators and their application to MAGDMAp. Xu and Zhou (2017) recognized a new idea of probabilistic hesitant fuzzy sets (PHFSs). In Ayub et al. (2021), the author developed a new decision method for decision support models.

Keshavarz et al. (2015) initially proposed EDAS to resolve numerous multi-attribute decision-making approaches. The EDAS method is very fruitful specially when the incompatible criteria happen in multi-attribute decision-making approach. Analogous to VIKOR method (Mirghafoori et al. 2018) and TOPSIS method (Liang et al. 2018), some traditional distances are also derived for EDAS method. Nevertheless, EDAS method should be considered as PDAS and NDAS on the base of average solution (AS). The finest alternative should have the major value of PDAS and the minimum value of NDAS (Keshavarz et al. 2016) . Kahraman et al. (2017) constructed EDAS method under IFSs. Keshavarz et al. (2017) applied the EDAS method to stochastic multi-attribute decision-making approach. Keshavarz et al. (2018) established EDAS method in dynamic multi-attribute decision-making approach. Stevic et al. (2018) considered one of the novel method based on the multicriteria analysis of fuzzy EDAS method to select the most appropriate manufacturer of PVC carpentry for the apartment refurbishing.

However, there are many findings in which the fuzzy EDAS approach is used to address decision-making problems, this type of decision-making data used by these methodologies is too old, limited and therefore can not effectively manage current decision-making environments. In addition, no matter what aggregation information is used in the fuzzy EDAS method, it may cause distortion of decision information. Therefore, the innovations of this paper are mainly the following aspects: firstly, utilized novel concept of the Pythagorean probabilistic hesitant fuzzy set (PyPHFS) established by Batool et al. (2020) to presented the new decision making technique to tackle the uncertain information in real life decision making. The motivation of the new concept is that in Probabilistic hesitant fuzzy set (PHFS) only positive membership degree is considered with probabilistic information, but PyPHFS is characterized by both positive hesitant membership and negative hesitant membership degrees, with the constraint that the square sum of positive and negative hesitant membership degrees is less than or equal to one. The DMs are limited to a specific domain in PHFS and ignore the negative degree of membership with its possible chance of occurrence. Compared to others, every negative hesitant membership degree also has some preference. For example, if one DM gives values 0.3, 0.4, 0.6 for a positive membership degree with their corresponding preference values 0.1 and 0.9, the other may reject the DMs may express their opinion in DM-problems in the form of several possible values. Under the proposed concept, the possibility of rejection with hesitation is considered. The information of chances will decrease in spite of HFSs and PHFSs. More details on the level of difference of opinion of the DMs are provided by the value of the probability of occurrence with positive and negative membership degrees. The key purpose of this manuscript is to establish PyPHF-EDAS model and to select an ideal drug to treat Coronavirus’s ailment.

The motivations of this paper can be established as: (1) It considers various specialists’ conclusions as the group hesitancy and breakers them into PyPHFSs. (2) In clinical analysis, how to choose an ideal drug from among certain drugs with alike efficacy values to treat ailments has become normal issues among specialists and patients. Generally, in clinical practice, it is problematic for specialists to precisely measure the exact efficacy value of a drug. That is, the efficacy values of drugs are usually imprecise. Consequently, this choice issue can be recognized as a MADM issue. This manuscript mainly deliberates an approach to select an appropriate drug from among certain drugs to treat Coronavirus’s ailment. As per the efficacy value of every drug about every indication, we can utilize a MADM algorithm to attain the positioning of all drugs and select an ideal drug. (3) This paper will consolidate the knowledge of conventional EDAS algorithm and the PyPHFN in managing with uncertain data to establish another decision-making algorithm and select an appropriate drug to treat Coronavirus’s ailment.

The arrangement of the manuscript is as per the following. Section 2 gives survey of FSs, IFSs, PyFSs, HFSs and PyHFSs and aggregation operators of PyHFSs. In Sect. 3 presented the aggregation operators for PyPHF. In Sect. 4, we exhibit the PyPHF-EDAS method to handle vagueness in DMAp. Section 5 explains application of the established MCDM algorithm. In Sect. 6 Comparison of established and TOPSIS method is given. In Sect. 7 conclusion and discussion of the manuscript is given.

Preliminaries

In this section, we sorts out the essential knowledge about fuzzy sets, hesitant fuzzy sets, probabilistic hesitant fuzzy sets, intuitionistic fuzzy sets and Pythagorean fuzzy sets.

Definition 1

(Zadeh 1965) For a fixed set F. A FS I in F is described as

I=g˙,τIg˙|g˙F,

for each g˙F, the positive membership grade τI:FΦ specifies the degree to which the element g˙I, where Φ=0,1.

Definition 2

(Atanassov 1986) For a fixed set F. An IFS I in F is described as

I=g˙,τIg˙,Ig˙|g˙F,

for each g˙F, the positive membership grade τI:FΦ and the negative membership grade I:FΦ specifies the positive and negative degrees of membership of g˙ to the IFS I, respectively, where Φ=0,1. Additionally, it is required that 0τIg˙+Ig˙1.

Definition 3

(Yager 2013) For a fixed set F. A PyFS I in F is described as

I=g˙,τIg˙,Ig˙|g˙F,

for each g˙F, the positive membership grade τI:FΦ and the negative membership grade I:FΦ specifies the positive and negative degrees of membership of g˙ to the PyFS I, respectively, where Φ=0,1. Additionally, it is required that 0τI2g˙+I2g˙1, for each g˙F. Conventionally, χϰ=1-τI2g˙-I2g˙ is said to be degree of hesitancy of g˙ to I.

In what follows, we represent by PyϝS^F the group of all Pythagorean fuzzy sets in F. For ease, we will represent the Pythagorean fuzzy number (PyFN) by the pair I=τI,I.

Definition 4

(Yager 2013) Let I1,I2PyϝS^F. Then(1) I1I2 if and only if τI1g˙τI2g˙ and I1g˙I2g˙ for each g˙F. Clearly I1=I2 if I1I2 and I2I1.(2) I1I2=minτI1g˙,τI2g˙,maxI1g˙,I2g˙|g˙F,(3) I1I2=maxτI1g˙,τI2g˙,minI1g˙,I2g˙|g˙F,(4) I1c=I1g˙,τI1g˙|g˙F.

Definition 5

(Torra 2010) For a fixed set F. A HFS Iin F is described as

I=g˙,hϰg˙|g˙F,

where hϰg˙ is in the form of set, that’s contained some possible values in unit interval, i.e.,0,1 which represent the membership degree of g˙F in I.

Definition 6

(Torra 2010) Let I1,I2HFSF. Then(1) I1c=ιhI1g˙1-ι;(2) I1I2=hI1g˙hI2g˙=ι1hI1g˙ι2hI2g˙maxι1,ι2;(3) I1I2=hI1g˙hI2g˙=ι1hI1g˙ι2hI2g˙minι1,ι2;

Definition 7

(Khan et al. 2017) For a fixed set F. A PyHFS I in F is presented as

I=g˙,τhϰg˙,hϰg˙|g˙F,

for each g˙F, the positive membership grade τI and the negative membership grade ϰ are sets in some values in 0,1, specifies the possible positive and negative degrees of membership of g˙ to the Pythagorean hesitant fuzzy set I, respectively. Furthermore, it is required that maxτhϰg˙2+minhϰg˙21 and minτhϰg˙2+maxhϰg˙21. For ease, we will represent the Pythagorean Hesitant Fuzzy Number (PyHFN) by the pair I=τhϰ,hϰ.

Definition 8

(Khan et al. 2017) Let I1=τhg˙1,hg˙1 and I2=τhg˙2,hg˙2 be two PyHFNs. The basic operational laws defined as

  1. I1I2=1τhg˙1(lg˙)2τhg˙2(lg˙)(max(1,2)),ϱ1hg˙1(lg˙)ϱ2hg˙2(lg˙)(min(ϱ1,ϱ2));
  2. I1I2=ϱ1hg˙1(lg˙)ϱ2hg˙2(lg˙)(min(ϱ1,ϱ2)),1τhg˙1(lg˙)2τhg˙2(lg˙)(max(1,2));
  3. I1c=hϰ,τhϰ

Definition 9

(Xu and Zhou 2017) For a fixed set F. A PHFS I in F is described as

I=g˙,hϰg˙/g˙|g˙F,

where hϰg˙ is subset of 0,1 and hϰg˙/g˙ represent the membership degree of g˙F in I. And g˙ represent the possibilities of hϰg˙, with constraint that g˙g˙=1.

Pythagorean probabilistic hesitant fuzzy set

Definition 10

(Batool et al. 2020) For a fixed set F. A PyPHFS I in F is described as

I=g˙,τhϰg˙/g˙,hϰg˙/g˙|g˙F,

for all g˙F, τhϰg˙ and hϰg˙ are sets of some values in 0,1. Where τhϰg˙/g˙ & hϰg˙/g˙ specifies the possible positive and negative degrees of membership of g˙ to the Pythagorean probabilistic hesitant fuzzy set I, respectively. g˙ and g˙ represent the possibilities of membership grades Also, there is 0 i,,ϱȷ^1 and 0i,ȷ^1 with i=1Li1,ȷ^=1Lȷ^1(L is a positive integer to describe the number of elements contained in PyPHFS), where iτhϰg˙,ϱȷ^hϰg˙,ig˙,ȷ^g˙. Additionally, it is required that maxτhϰg˙2+minhϰg˙21 and minτhϰg˙2+maxhϰg˙21.

For ease, we will represent the Pythagorean Probabilistic Hesitant Fuzzy Number (PyPHFN) by the pair I=τhϰ/g˙,hϰ/g˙.The group of all Pythagorean probabilistic hesitant fuzzy sets in F is represented by PyPHϝS^F.

Definition 11

(Batool et al. 2020) Let I1=τhg˙1/g˙1,hg˙1/g˙1 and I2=τhg˙2/g˙2,hg˙2/g˙2 be two PyPHFNs. The basic operational laws defined as

  1. I1I2=1τhg˙1(lg˙),1g˙12τhg˙2(lg˙),2g˙2(max(1/1,2/2)),ϱ1hg˙1(lg˙),1g˙1ϱ2hg˙2(lg˙),2g˙2(min(ϱ1/1,ϱ2/2));
  2. I1I2=1τhg˙1(lg˙),1g˙12τhg˙2(lg˙),2g˙2(min(1/1,2/2)),ϱ1hg˙1(lg˙),1g˙1ϱ2hg˙2(lg˙),2g˙2(max(ϱ1/1,ϱ2/2));
  3. I1c=hϰ/g˙,τhϰ/g˙

Definition 12

Let I1=τhg˙1/g˙1,hg˙1/g˙1 and I2=τhg˙2/g˙2,hg˙2/g˙2 be two PyPHFNs and ζ>0(R), then their operations are presented as:

  1. I1I2=1τhg˙1(lg˙),2τhg˙2(lg˙)1g˙1,2g˙212+22-1222/12,ϱ1hg˙1(lg˙),ϱ2hg˙2(lg˙)1g˙1,2g˙2(ϱ1ϱ2/12);
  2. I1I2=1τhg˙1(lg˙),2τhg˙2(lg˙)1g˙1,2g˙212/12,ϱ1hg˙1(lg˙),ϱ2hg˙2(lg˙)1g˙1,2g˙2ϱ12+ϱ22-ϱ12ϱ22/12;
  3. ζI1=1τhg˙1(lg˙),1g˙11-(1-12)ζ/1,ϱ1hg˙1(lg˙),1g˙1ϱ1ζ/1;
  4. I1ζ=1τhg˙1(lg˙),1g˙11ζ/1,ϱ1hg˙1(lg˙),1g˙11-(1-ϱ12)ζ/1.

Definition 13

For any PyPHFN I=τhϰ/g˙,hϰ/g˙, a score function be defined as

s(I)=1MIiτhg˙,ihg˙(i·i)2-1NIϱihϰ,ihg˙(ϱi·i)2,

where MI represents the number of elements in τhϰ and NI represents the number of elements in hϰ.

Definition 14

For any PyPHFN I=τhϰ/g˙,hϰ/g˙, an accuracy function is defined as

h(I)=1MIiτhg˙,ihg˙(i·i)2+1NIϱihϰ,ihg˙(ϱi·i)2,

where MI represents the number of elements in τhϰ and NI represents the number of elements in hϰ.

Definition 15

Let I1=τhg˙1/g˙1,hg˙1/g˙1 and I2=τhg˙2/g˙2,hg˙2/g˙2 be two PyPHFNs. Then by using above definition, comparison of PyPHFNs can be described as(1) If s(I1)>s(I2), then I1>I2.(2) If s(I1)=s(I2), and h(I1)>h(I2) then I1>I2.

Definition 16

(Khan et al. 2018) Let Iȷ^=τhg˙ȷ^,hg˙ȷ^ (ȷ^=1,2,,d) be a group of all PyHFNs, and =(1,2,,d)T are the weights of Iȷ^, ȷ^0, with ȷ^=1dȷ^=1. Then PyHFWA operator PyHFWA:PyHFNdPyHFN can be described as

PyHFWA(I1,I2,,Id)=1I12I2dId=ȷ^=1dȷ^Iȷ^

Definition 17

(Khan et al. 2018) Let Iȷ^=τhg˙ȷ^,hg˙ȷ^ (ȷ^=1,2,,d) be a group of all PyHFNs, and =(1,2,,d)T are the weights of Iȷ^, ȷ^0, with ȷ^=1dȷ^=1. Then PyHFWG operator PyHFWG:PyHFNdPyHFN can be described as

PyHFWG(I1,I2,,Id)=I11I22Idd=ȷ^=1dIȷ^ȷ^

Definition 18

(Khan et al. 2018) Let Iȷ^=τhg˙ȷ^,hg˙ȷ^ (ȷ^=1,2,,d) be a group of all PyHFNs, Iκ(ȷ^) be the jth largest in them and =(1,2,,d)T are the weights of Iȷ^ [0,1] with ȷ^=1dȷ^=1. Then PyHFOWA operator PyHFOWA:PyHFNdPyHFN can be described as

PyHFOWA(I1,I2,,Id)=1Iκ(1)2Iκ(2)dIκ(d)=ȷ^=1dȷ^Iκ(ȷ^)

Definition 19

(Khan et al. 2018) Let Iȷ^=τhg˙ȷ^,hg˙ȷ^ (ȷ^=1,2,,d) be a group of all PyHFNs, Iκ(ȷ^) be the jth largest in them and =(1,2,,d)T are the weights of Iȷ^ [0, 1] with ȷ^=1dȷ^=1. Then PyHFOWG operator PyHFOWG:PyHFNdPyHFN can be described as

PyHFOWG(I1,I2,,Id)=Iκ(1)1Iκ(2)2Iκ(d)d=ȷ^=1dIκ(ȷ^)ȷ^

Aggregation information for PyPHFNs

This section presents some aggregation operators for Pythagorean Probabilistic hesitant fuzzy numbers derived from operational laws.

Definition 20

Let Iȷ^=τhg˙ȷ^/g˙ȷ^,hg˙ȷ^/g˙ȷ^ (ȷ^=1,2,,d) be any group of PyPHFNs and PyPHFWA:PyPHFNdPyPHFN. Then PyPHFWA operator can be described as

PyPHFWA(I1,I2,,Id)=1I12I2dId=ȷ^=1dȷ^Iȷ^,

where =(1,2,,d)T are the weights of Iȷ^[0,1] with ȷ^=1dȷ^=1.

Theorem 1

Let Iȷ^=τhg˙ȷ^/g˙ȷ^,hg˙ȷ^/g˙ȷ^ (ȷ^=1,2,,d) be any group of PyPHFNs. Then the aggregation result using PyPHFWA, we can achieve the following

PyPHFWA(I1,I2,,Id)=ȷ^τIȷ^,Iȷ^Iȷ^1-Πȷ^=1d1-Iȷ^2ȷ^/Πȷ^=1dIȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^Πȷ^=1dϱIȷ^ȷ^/Πȷ^=1dIȷ^

where =(1,2,,d)T are the weights of Iȷ^[0,1] with ȷ^=1dȷ^=1.

Proof

We will demonstrate the theorem by following the steps mathematical induction on r, and the proof is executed as beneath:

Step 1 When d=2, we have I1=τhg˙1/g˙1,hg˙1/g˙1 and I2=τhg˙2/g˙2,hg˙2/g˙2 Thus, by the operation of PyPHFEs, we achieve

1I1=1τhg˙1(lg˙),1g˙11-(1-12)1/1,ϱ1hg˙1(lg˙),1g˙1ϱ11/12I2=2τhg˙2(lg˙),2g˙21-(1-22)2/2,ϱ2hg˙2(lg˙),2g˙2ϱ22/2

Now,

PyPHFWA(I1,I2)=1I12I2=1τhg˙1(lg˙),1g˙12τhg˙2(lg˙),2g˙21-(1-12)1+1-(1-22)2-(1-(1-12)1)(1-(1-22)2)/12,ϱ1hg˙1(lg˙),1g˙1ϱ2hg˙2(lg˙),2g˙2ϱ11/1ϱ22/2=1τhg˙1(lg˙),1g˙12τhg˙2(lg˙),2g˙21-(1-12)1(1-22)2/12,ϱ1hg˙1(lg˙),1g˙1ϱ2hg˙2(lg˙),2g˙2ϱ11ϱ22/12=1τhg˙1(lg˙),1g˙12τhg˙2(lg˙),2g˙21-Πȷ^=12(1-ȷ^2)ȷ^/Πȷ^=12ȷ^,ϱ1hg˙1(lg˙),1g˙1ϱ2hg˙2(lg˙),2g˙2Πȷ^=12ϱȷ^ȷ^/Πȷ^=12ȷ^.

Thus, the result holds for r=2.

Step 2 Assume that the result holds for r=n, we have

PyPHFWA(I1,I2,,In)=ȷ^τIȷ^,Iȷ^Iȷ^1-Πȷ^=1n1-Iȷ^2ȷ^/Πȷ^=1nIȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^Πȷ^=1nϱIȷ^ȷ^/Πȷ^=1nIȷ^.

When r=n+1, then we have

PyPHFWA(I1,I2,,In+1)=ȷ^=1nȷ^Iȷ^n+1In+1=ȷ^τIȷ^,Iȷ^Iȷ^1-Πȷ^=1n1-Iȷ^2ȷ^/Πȷ^=1nIȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^Πȷ^=1nϱIȷ^ȷ^/Πȷ^=1nIȷ^n+1τIn+1,In+1In+11-1-In+12n+1/In+1,ϱIn+1In+1,In+1In+1ϱIn+1ȷ^/In+1=ȷ^τIȷ^,Iȷ^Iȷ^1-Πȷ^=1n+11-Iȷ^2ȷ^/Πȷ^=1n+1Iȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^Πȷ^=1n+1ϱIȷ^ȷ^/Πȷ^=1n+1Iȷ^.

Thus it is ture for all d.

7PyPHFWA(I1,I2,,Id)=ȷ^τIȷ^,Iȷ^Iȷ^1-Πȷ^=1d1-Iȷ^2ȷ^/Πȷ^=1dIȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^Πȷ^=1dϱIȷ^ȷ^/Πȷ^=1dIȷ^.

Proved.

Definition 21

Let Iȷ^=τhg˙ȷ^/g˙ȷ^,hg˙ȷ^/g˙ȷ^ (ȷ^=1,2,,d) be any group of PyPHFNs, and PyPHFOWA:PyPHFNdPyPHFN.Then PyPHFOWA operator can be described as

PyPHFOWA(I1,I2,,Id)=1Iκ(1)2Iκ(2)dIκ(d)=ȷ^=1dȷ^Iκȷ^

where Iκ(ȷ^) be the jth largest in them and =(1,2,,d)T are the weights of Iȷ^ [0, 1] with ȷ^=1dȷ^=1.

Theorem 2

Let Iȷ^=τhg˙ȷ^/g˙ȷ^,hg˙ȷ^/g˙ȷ^ (ȷ^=1,2,,d) be any group of PyPHFNs. Then the aggregation result using PyPHFOWA, we can achieve the following

PyPHFOWA(I1,I2,,Id)=Iκ(ȷ^)τIκ(ȷ^)Iκ(ȷ^)τIκ(ȷ^)1-Πȷ^=1d1-Iκ(ȷ^)2ȷ^/Πȷ^=1dIκ(ȷ^),ϱIκ(ȷ^)Iκ(ȷ^)Iκ(ȷ^)Iκ(ȷ^)Πȷ^=1dϱIκ(ȷ^)ȷ^/Πȷ^=1dIκ(ȷ^)

where Iκ(ȷ^) be the jth largest in them and =(1,2,,d)T are the weights of Iȷ^[0,1] with ȷ^=1dȷ^=1.

Proof

Prove is similarly as Theorem 1.

Definition 22

Let Iȷ^=τhg˙ȷ^/g˙ȷ^,hg˙ȷ^/g˙ȷ^ (ȷ^=1,2,.,d) be any group of PyPHFNs, and PyPHFWG:PyPHFNdPyPHFN. Then PyPHFWG operator can be described as

PyPHFWG(I1,I2,,Id)=I11I22Idd=ȷ^=1dIȷ^ȷ^

and =(1,2,,d)T are the weights of Iȷ^[0,1] with ȷ^=1dȷ^=1.

Theorem 3

Let Iȷ^=τhg˙ȷ^/g˙ȷ^,hg˙ȷ^/g˙ȷ^ (ȷ^=1,2,,d) be any group of PyPHFNs. Then the aggregation result using PyPHFWG, we can achieve the following

PyPHFWG(I1,I2,,Id)=ȷ^τIȷ^,Iȷ^Iȷ^Πȷ^=1dȷ^ȷ^/Πȷ^=1dȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^1-Πȷ^=1d1-ϱȷ^2ȷ^/Πȷ^=1dȷ^

where =(1,2,,d)T are the weights of Iȷ^[0,1] with ȷ^=1dȷ^=1.

Proof

We will demonstrate the theorem by following the steps mathematical induction on r, and the proof is executed as beneath:

Step 1 When d=2, we have I1=τhg˙1/g˙1,hg˙1/g˙1 and I2=τhg˙2/g˙2,hg˙2/g˙2 Thus, by the operation of PyPHFEs, we achieve

I11=1τhg˙1(lg˙),1g˙111/1,ϱ1hg˙1(lg˙),1g˙11-(1-ϱ12)1/1I22=2τhg˙2(lg˙),2g˙222/2,ϱ2hg˙2(lg˙),2g˙21-(1-ϱ22)2/2

Now,

PyPHFWG(I1,I2)=I11I22=1τhg˙1(lg˙),1g˙12τhg˙2(lg˙),2g˙211/122/2,ϱ1hg˙1(lg˙),1g˙1ϱ2hg˙2(lg˙),2g˙21-(1-ϱ12)1+1-(1-ϱ22)2-(1-(1-ϱ12)1)(1-(1-ϱ22)2)/12=1τhg˙1(lg˙),1g˙12τhg˙2(lg˙),2g˙21122/12,ϱ1hg˙1(lg˙),1g˙1ϱ2hg˙2(lg˙),2g˙21-(1-ϱ12)1(1-ϱ22)2/12=1τhg˙1(lg˙),1g˙12τhg˙2(lg˙),2g˙2Πȷ^=12ȷ^ȷ^/Πȷ^=12ȷ^,ϱ1hg˙1(lg˙),1g˙1ϱ2hg˙2(lg˙),2g˙21-Πȷ^=121-ϱȷ^2ȷ^/Πȷ^=12ȷ^

Thus, the result holds for r=2.

Step 2 Assume that the result holds for r=n, we have

PyPHFWG(I1,I2,,In)=ȷ^τIȷ^,Iȷ^Iȷ^Πȷ^=1nȷ^ȷ^/Πȷ^=1nȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^1-Πȷ^=1n1-ϱȷ^2ȷ^/Πȷ^=1nȷ^

When r=n+1, then we have

PyPHFWG(I1,I2,,In+1)=ȷ^=1nIȷ^ȷ^In+1n+1=ȷ^τIȷ^,Iȷ^Iȷ^Πȷ^=1dȷ^ȷ^/Πȷ^=1dȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^1-Πȷ^=1d1-ϱȷ^2ȷ^/Πȷ^=1dȷ^n+1τhg˙n+1(lg˙),n+1g˙n+1n+1n+1/n+1,ϱn+1hg˙n+1(lg˙),n+1g˙n+11-(1-ϱn+12)n+1/n+1=ȷ^τIȷ^,Iȷ^Iȷ^Πȷ^=1n+1ȷ^ȷ^/Πȷ^=1n+1ȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^1-Πȷ^=1n+11-ϱȷ^2ȷ^/Πȷ^=1n+1ȷ^

Thus

PyPHFWG(I1,I2,,Id)=ȷ^τIȷ^,Iȷ^Iȷ^Πȷ^=1dȷ^ȷ^/Πȷ^=1dȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^1-Πȷ^=1d1-ϱȷ^2ȷ^/Πȷ^=1dȷ^.

Proved.

Definition 23

Let Iȷ^=τhg˙ȷ^/g˙ȷ^,hg˙ȷ^/g˙ȷ^ (ȷ^=1,2,,d) be any group of PyPHFNs, and PyPHFOWG:PyPHFNdPyPHFN.Then PyPHFOWG operator can be described as

PyPHFOWG(I1,I2,,Id)=Iκ(1)1Iκ(2)2Iκ(d)d=ȷ^=1dIκȷ^ȷ^,

where Iκ(ȷ^) be the jth largest in them and =(1,2,,d)T are the weights of Iȷ^ [0, 1] with ȷ^=1dȷ^=1.

Theorem 4

Let Iȷ^=τhg˙ȷ^/g˙ȷ^,hg˙ȷ^/g˙ȷ^ (ȷ^=1,2,,d) be any group of PyPHFNs. Then the aggregation result using PyPHFOWG, we can achieve the following

PyPHFOWG(I1,I2,,Id)=ȷ^τIȷ^,Iȷ^Iȷ^Πȷ^=1dIκ(ȷ^)ȷ^/Πȷ^=1dIκ(ȷ^),ϱIȷ^Iȷ^,Iȷ^Iȷ^1-Πȷ^=1d1-ϱIκ(ȷ^)2ȷ^/Πȷ^=1dIκ(ȷ^),

where Iκ(ȷ^) be the jth largest in them and =(1,2,,d)T are the weights of Iȷ^[0,1] with ȷ^=1dȷ^=1.

Proof

Prove is similarly as Theorem 3.

EDAS approach for MAGDM based on PyPHFNs

Now we establish a framework for solving MAGDM issues under PyPHF information.

Let a1,a2,,ap be a set of p alternatives and let I1,I2,,Id be a set of attributes with weight vector =(1,2,,d) where t[0,1] and t=1dt=1. To assess the performance of kth alternative ak under the tth attribute It, let D˚1,D˚2,,D˚ȷ^ be a set of experts and σ=(σ1,σ2,,σȷ^) be the weighted vector of experts with σs[0,1] and s=1ȷ^σs=1. On the basis of the conventional EDAS algorithm, the EDAS algorithm for MAGDM is established under PyPHF environment. Key steps are described as:

  • Step 1
    Construct the PyPHF decision matrix based on the experts evaluations.
    C=Iktsp×d=τkts/kt,kts/ktp×ds=1,2,,ȷ^;k=1,2,,p;t=1,2,,d.
  • Step 2
    Utilize Pythagorean probabilistic hesitant fuzzy weighted averaging aggregation operators to achieve the overall PyPHF information.
    PyPHFWA(I1,I2,,Id)=ȷ^τIȷ^,Iȷ^Iȷ^1-Πȷ^=1d1-Iȷ^2ȷ^/Πȷ^=1dIȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^Πȷ^=1dϱIȷ^ȷ^/Πȷ^=1dIȷ^
  • Step 3
    Determine the AS of all the alternatives under each attribute.
    AS=AS1,AS2,,ASt,
    where
    ASt=τk/k,k/k=1pIk11pIk21pIkd=ȷ^τIȷ^,Iȷ^Iȷ^1-Πȷ^=1p1-Iȷ^21p/Πȷ^=1pIȷ^,ϱIȷ^Iȷ^,Iȷ^Iȷ^Πȷ^=1pϱIȷ^1p/Πȷ^=1pIȷ^t=1,2,,d
  • Step 4
    Determine the PDAS and NDAS matrices.
    PDAS=PDASktp×dNDAS=NDASktp×d
    where
PDASkt=max0,S(Ikt-SAStSAStNDASkt=max0,SASt-S(Ikt)SASt,

where S(Ikt), and SASt are score function

  • Step 5
    Calculate the positive weighted distance SPkk=1,2,,p and the negative weighted distance SNkk=1,2,,p:
    SPk=t=1dtPDASktSNk=t=1dtNDASkt,
    where t0,1,t=1dt=1.
  • Step 6
    Normalize the SPkk=1,2,,p and SNkk=1,2,,p in the way given as:
    NSPk=SPkmaxSP1,SP2,,SPpNSNk=SNkmaxSN1,SN2,,SNp
  • Step 7
    Calculate the integrative appraisal score IASkk=1,2,,p in the way given as:
    IASk=12NSPk+1-NSNk
    Where IASk0,1.
  • Step 8

    Calculate the ordering according to the result of IASkk=1,2,,p. The larger IASk, is the best alternative.

Numerical example

To validate our established algorithm we consider the case of selecting an optimal drug to treat Coronavirus’s ailment.

Case study

In the present climate, Coronavirus’s ailment is one of the fatal ailments among the elderly, which is rapidly spreading all over the world and characterized by fever, cold, cough, breathing problems, sore throat, headache and so on. There is as of now no immediate and effective drug to treat it. In clinical practice, drugs to treat Coronavirus’s ailment are fundamentally symbolic medicines to control the flue, cough, weak immune system, etc. In the clinical practice, specialists generally combine many drugs to treat Coronavirus’s ailment.

Let a1,a2,a3,a4 be a set of drugs and let I1,I2,I3 be a set of symptoms. Generally, from a medical opinion, the border of an attribute value is normally imprecise. We can accomplish that inadequacy, fuzziness and vagueness are inherent structures of clinical practice. Consequently, the efficacy value of drugs w.r.t. a symptom can be viewed as a fuzzy set. The weight vector for symptoms is φ = (0.314,0.355,0.331)T. So as to keep away from the danger of abuse and misdiagnosis in the treatment of Coronavirus’s ailment, specialists ought to assess drug’s efficacy values w.r.t. all symptoms in combination with their involvement in clinic and select an appropriate drug to treat it.

I1 = Fever,

I2 = Breathing problem,

I3 = Cough

The estimation values of the alternatives regarding each criterion provided by the specialists are developed by PyPHFNs as revealed in the PyPHF decision matrix given in Table 1. To solve the MCDM issue by developed operators, the following calculations are achieved:

Table 1.

Normalized collective data of experts

I1 I2 I3
a1 0.48/0.4,0.4/0.60.49/1 0.65/10.02/0.5,0.7/0.5 0.7/0.1,0.7/0.90.09/0.1,0.1/0.9
a2 0.5/0.8,0.52/0.20.5/1 0.3/10.03/0.6,0.5/0.4 0.8/10.65/0.2,0.3/0.8
a3 0.2/0.7,0.4/0.30.4/1 0.2/10.5/0.8,0.4/0.2 0.3/0.2,0.6/0.80.75/0.7,0.2/0.3
a4 0.52/0.8,0.7/0.20.4/1 0.6/10.7/0.2,0.2/0.8 0.2/10.09/0.5,0.5/0.5
Step 1
Calculate the AS of all the alternatives under each attribute by using PyPHFWA operator.
AS1=k1τIk1Ik1Ik11-Πk=141-Ik121/4/Πk=14Ik1,ϱIk1Ik1Ik1Ik1Πk=14ϱIk11/4/Πk=14Ik1
Similarly for other attribute.
Step 2

Calculated score values of ASt(t=1,2,3,) is shown in Table 2.

Table 2.

S(ASt)

-0.19716 0.24639 0.02494

After that, we calculated the score of Table 1 in Table 3.

Table 3.

The score matrix of Table 1

I1 I2 I3
a1 -0.1934 0.3901 0.1201
a2 -0.1865 0.0781 0.6058
a3 -0.1431 -0.0176 -0.0127
a4 -0.0827 0.3375 0.0182
Step 3

By exploited the score values, calculate the PDAS and NDAS in Table 4.

Table 4.

PDAS matrix and NDAS matrix

I1 I2 I3
(a) PDAS matrix
a1 -0.01885 0.583256 3.812771
a2 -0.05409 0 23.2854
a3 -0.27419 0 0
a4 -0.58046 0.369774 0
(b) NDAS matrix
a1 0 0 0
a2 0 0.682974 0
a3 0 1.071431 1.507387
a4 0 0 0.268612
Step 4

Calculated the positive weighted distance SPkk=1,2,3,4 and the negative weighted distance SNkk=1,2,,p,where φ = (0.314,0.355,0.331)T in Table 5 .

Table 5.

SPk and SNk

(a)SPk
1.463165 7.690484 -0.0861 -0.051
(b)SNk
0 0.242446 0.879303 0.08891
Step 5

Normalized the values SPkk=1,2,3,4 and SNkk=1,2,,p is shown in Table 6.

Table 6.

NSPk and NSNk

(a) NSPk
0.190257 1 1.688322 1
(b) NSNk
0 0.275725 1 0.101115
Step 6

Calculated the values of IASkk=1,2,3,4 in Table 7.

Table 7.

IASk

0.60 0.86 0.84 0.95
Step 7
IAS4>IAS2>IAS3>IAS1.
Therefore,
a4>a2>a3>a1.
The best drug is a4.

We can conclude from this above computational process that a4 is the best drug for the COVID-19 patients, among others, and therefore it is highly recommended.

Comparison analysis

To validate the effectiveness of PyPHF-EDAS algorithm, a comparison between PyPHF-EDAS algorithm (Table 8) and PyPHF-TOPSIS algorithm is taken into account. The ranking of the drugs with weight vector φ=(0.01,0.35,0.64) is listed in Table-8.

Table 8.

Comparison matrix

Methods Scores Ranking
a1 a2 a3 a4
TOPSIS (Batool et al. 2020) 0.03 0.81 0.86 0.99 a4>a3>a2>a1
EDAS 0.60 0.86 0.84 0.95 a4>a2>a3>a1

Comparison between TOPSIS algorithm and extended form of EDAS algorithm shows that the best and worst alternative are same. EDAS algorithm is steady and progressive when various weights for the criteria are allocated. The evaluations of alternatives in EDAS algorithm depend on the distance measure from the average solution dissimilar to TOPSIS algorithm. As Compare to other MCDM algorithms, EDAS algorithm has required less calculations.

Thus, the EDAS algorithm is an enhanced form of the existing algorithms because it considers the conflicting attributes. Moreover, the best and worst alternative chosen by the EDAS algorithm remains the same as that with that of the TOPSIS algorithm signifies that the established algorithm is an enhanced version of existing algorithms. The recently developed EDAS technique is utilized to choose an appropriate drug to treat Coronavirus patients based on the average solution under PyPHF environment. We Compare TOPSIS algorithm and recently developed EDAS algorithm which shows that the best and worst alternative are same. The EDAS approach has more statistical simplicity and the potential to produce more accurate results. The evaluations of alternatives in EDAS algorithm depend on the distance measure from the average solution dissimilar to TOPSIS algorithm. As Compare to other MCDM algorithms, EDAS algorithm has required less calculations. Moreover, the best and worst alternative chosen by the EDAS algorithm remains the same as that with that of the TOPSIS algorithm signifies that the established algorithm is an enhanced version of existing algorithm.

Conclusion

Pythagorean probabilistic hesitant fuzzy set is an enhanced form of Pythagorean fuzzy set and probabilistic hesitant fuzzy set. It consider probabilistic hesitant information, so, there is no loss of information. Nowadays, selection of an best drug to treat COVID-19 patients has become serious issue between specialists and doctors. To tackle this issue, we have established a PyPHF-EDAS based aggregation information technique to tackle the uncertain information in multi-attribute emergency decision making situation of COVID-19. In addition using proposed technique, we developed an algorithm to tackle MADM problems. We developed a method to select an ideal drug from certain drugs with efficacy values for coronavirus disease. We established a multi attribute decision-making approach based on the EDAS method under Pythagorean probabilistic hesitant fuzzy information. We choose the EDAS method because it has a significant role in the decision-making problems especially when more conflict criteria exist in MCGDM problems. This method is based on PDAS and NDAS from Average solution. These two measures indicate the difference between each solution and the Average solution. Superior value of PDAS and inferior value of NDAS is considered the optimal choice. To study the hybrid structure of EDAS method with PyPHFN, we get PyPHF-EDAS method. The aim of this manuscript is to present PyPHF- EDAS method based on PyPHF averaging aggregation operator. We used the knowledge of conventional EDAS algorithm and the PyPHFN in managing with uncertain data to establish another decision-making algorithm and select an appropriate drug to treat Coronavirus ailment.The main benefit of established algorithm is that it takes the probabilistic information to each positive and negative hesitant membership degrees into account which give more details without any loss of information. The established algorithm has been signified with a medical diagnosis example (to select an appropriate drug to treat Coronavirus’s patients) to show the validity and effectiveness of our established technique under PyPHF information. Lastly, a comparative study has been considered between established algorithm and TOPSIS algorithm to shows the validity and applicability of the proposed technique.

In the future, we will establish the TODIM and VIKOR methodology based generalized aggregation information within the framework of Pythagorean probabilistic hesitant fuzzy information to tackle uncertain information in decision making problems.

Acknowledgements

This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under the grant No. (DF-192-980-1441). The authors, therefore, gratefully acknowledge DSR technical and financial support.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Bushra Batool, Email: bushra.batool@uos.edu.pk.

Shougi Suliman Abosuliman, Email: sabusuliman@kau.edu.sa.

Saleem Abdullah, Email: saleemabdullah@awkum.edu.pk.

Shahzaib Ashraf, Email: shahzaibashraf@bkuc.edu.pk.

References

  1. Ashraf S, Abdullah S. Emergency decision support modeling for COVID-19 based on spherical fuzzy information. Int J Intell Syst. 2020;35(11):1601–1645. doi: 10.1002/int.22262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashraf S, Abdullah S, Almagrabi AO. A new emergency response of spherical intelligent fuzzy decision process to diagnose of COVID19. Soft Comput. 2020 doi: 10.1007/s00500-020-05287-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ashraf S, Abdullah S, Khan S. Fuzzy decision support modeling for internet finance soft power evaluation based on sine trigonometric Pythagorean fuzzy information. J Ambient Intell Hum Comput. 2021;12(2):3101–3119. doi: 10.1007/s12652-020-02471-4. [DOI] [Google Scholar]
  4. Atanassov K. Intuitionistic fuzzy sets. Fuzzy Sets Syst. 1986;20(1):87–96. doi: 10.1016/S0165-0114(86)80034-3. [DOI] [Google Scholar]
  5. Ayub S, Abdullah S, Ghani F, et al. Cubic fuzzy Heronian mean Dombi aggregation operators and their application on multi-attribute decision-making problem. Soft Comput. 2021;25:4175–4189. doi: 10.1007/s00500-020-05512-4. [DOI] [Google Scholar]
  6. Balas EA, Weingarten S, Garb CT, Blumenthal D, Boren SA, Brown GD. Improving preventive care by prompting physicians. Arch Intern Med. 2000;160(3):301–308. doi: 10.1001/archinte.160.3.301. [DOI] [PubMed] [Google Scholar]
  7. Batool B, Ahmad M, Abdullah S, Ashraf S, Chinram R. Entropy based Pythagorean probabilistic hesitant fuzzy decision making technique and its application for fog-haze factor assessment problem. Entropy. 2020;22(3):318. doi: 10.3390/e22030318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, Sam J, Haynes RB. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293(10):1223–1238. doi: 10.1001/jama.293.10.1223. [DOI] [PubMed] [Google Scholar]
  9. Kahraman C, Keshavarz GM, Zavadskas EK, Cevik OS, Yazdani M, Oztaysi B. Intuitionistic fuzzy EDAS method: an application to solid waste disposal site selection. J Environ Eng Landsc. 2017;25(1):1–12. doi: 10.3846/16486897.2017.1281139. [DOI] [Google Scholar]
  10. Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330(7494):765. doi: 10.1136/bmj.38398.500764.8F. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Keshavarz GM, Zavadskas EK, Olfat L, Turskis Z. Multi-criteria inventory classification using a new method of evaluation based on distance from average solution (EDAS) Informatica. 2015;26(3):435–451. doi: 10.15388/Informatica.2015.57. [DOI] [Google Scholar]
  12. Keshavarz GM, Zavadskas EK, Amiri M, Turskis Z. Extended EDAS method for fuzzy multi-criteria decision-making: an application to supplier selection. Int J Comput Commun. 2016;11(3):358–371. doi: 10.15837/ijccc.2016.3.2557. [DOI] [Google Scholar]
  13. Keshavarz GM, Amiri M, Zavadskas EK, Turskis Z, Antucheviciene J. Stochastic EDAS method for multi-criteria decision-making with normally distributed data. J Intell Fuzzy Syst. 2017;33(3):1627–1638. doi: 10.3233/JIFS-17184. [DOI] [Google Scholar]
  14. Keshavarz GM, Amiri M, Zavadskas EK, Turskis Z, Antucheviciene J. A dynamic fuzzy approach based on the EDAS method for multi-criteria subcontractor evaluation. Information. 2018;9(3):68. doi: 10.3390/info9030068. [DOI] [Google Scholar]
  15. Khan MSA, Abdullah S, Ali A, Siddiqui N, Amin F. Pythagorean hesitant fuzzy sets and their application to group decision making with incomplete weight information. J Intell Fuzzy Syst. 2017;33(6):3971–3985. doi: 10.3233/JIFS-17811. [DOI] [Google Scholar]
  16. Khan MSA, Abdullah S, Ali A, Rahman K. Pythagorean hesitant fuzzy information aggregation and their application to multi-attribute group decision-making problems. J Intell Syst. 2018;29(1):154–171. [Google Scholar]
  17. Khan AA, Ashraf S, Abdullah S, Qiyas M, Luo J, Khan SU. Pythagorean fuzzy Dombi aggregation operators and their application in decision support system. Symmetry. 2019;11(3):383. doi: 10.3390/sym11030383. [DOI] [Google Scholar]
  18. Khan MJ, Kumam P, Liu P, Kumam W, Ashraf S. A novel approach to generalized intuitionistic fuzzy soft sets and its application in decision support system. Mathematics. 2019;7(8):742. doi: 10.3390/math7080742. [DOI] [Google Scholar]
  19. Khan MSA, Abdullah S, Ali A, Amin F, Rahman K. Hybrid aggregation operators based on Pythagorean hesitant fuzzy sets and their application to group decision making. Granul Comput. 2019;4(3):469–482. doi: 10.1007/s41066-018-0107-4. [DOI] [Google Scholar]
  20. Khan MA, Ashraf S, Abdullah S, Ghani F. Applications of probabilistic hesitant fuzzy rough set in decision support system. Soft Comput. 2020;24:16759–16774. doi: 10.1007/s00500-020-04971-z. [DOI] [Google Scholar]
  21. Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, Goldhaber SZ. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352(10):969–977. doi: 10.1056/NEJMoa041533. [DOI] [PubMed] [Google Scholar]
  22. Liang D, Xu Z, Liu D, Wu Y. Method for three-way decisions using ideal TOPSIS solutions at Pythagorean fuzzy information. Inform Sci. 2018;435:282–295. doi: 10.1016/j.ins.2018.01.015. [DOI] [Google Scholar]
  23. Liao H, Xu Z. Extended hesitant fuzzy hybrid weighted aggregation operators and their application in decision making. Soft Comput. 2015;19:2551–2564. doi: 10.1007/s00500-014-1422-6. [DOI] [Google Scholar]
  24. Liao H, Xu Z. Some new hybrid weighted aggregation operators under hesitant fuzzy multi-criteria decision making environment. J Intell Fuzzy Syst. 2014;26(4):1601–1617. doi: 10.3233/IFS-130841. [DOI] [Google Scholar]
  25. Liu J, Sun M. Generalized power average operator of hesitant fuzzy numbers and its application in multiple attribute decision making. J Comput Inf Syst. 2013;9(8):3051–3058. [Google Scholar]
  26. Lunin LF, Hersh WR. Perspectives on... medical informatics: information technology in healthcare. J Am Soc Inf Sci Technol. 1995;46(10):725–800. doi: 10.1002/(SICI)1097-4571(199512)46:10<725::AID-ASI2>3.0.CO;2-H. [DOI] [Google Scholar]
  27. Mirghafoori SH, Izadi MR, Daei A. Analysis of the barriers affecting the quality of electronic services of libraries by VIKOR, FMEA and entropy combined approach in an intuitionistic-fuzzy environment. J Intell Fuzzy Syst. 2018;34(4):2441–2451. doi: 10.3233/JIFS-171695. [DOI] [Google Scholar]
  28. Pauker SG, Gorry GA, Kassirer JP, Schwartz WB. Towards the simulation of clinical cognition: taking a present illness by computer. Am J Med. 1976;60(7):981–996. doi: 10.1016/0002-9343(76)90570-2. [DOI] [PubMed] [Google Scholar]
  29. Peleg M, Tu S. Decision support, knowledge representation and management in medicine. Yearb Med Inform. 2006;45:72–80. [PubMed] [Google Scholar]
  30. Peng X, Yang Y. Some results for Pythagorean fuzzy sets. Int J Intell Syst. 2015;30(11):1133–1160. doi: 10.1002/int.21738. [DOI] [Google Scholar]
  31. Roshanov PS, You JJ, Dhaliwal J, Koff D, Mackay JA, Weise-Kelly L, Navarro T, Wilczynski NL, Haynes RB. Can computerized clinical decision support systems improve practitioners’ diagnostic test ordering behavior? A decision-maker-researcher partnership systematic review. Implement Sci. 2011;6(1):1–12. doi: 10.1186/1748-5908-6-88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sittig DF, Wright A, Osheroff JA, Middleton B, Teich JM, Ash JS, Campbell E, Bates DW. Grand challenges in clinical decision support. J Biomed Inform. 2008;41(2):387–392. doi: 10.1016/j.jbi.2007.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Stević Ž, Vasiljević M, Zavadskas EK, Sremac S, Turskis Z. Selection of carpenter manufacturer using fuzzy EDAS method. Eng Econ. 2018;29(3):281–290. doi: 10.5755/j01.ee.29.3.16818. [DOI] [Google Scholar]
  34. Torra V. Hesitant fuzzy sets. Int J Intell Syst. 2010;25(6):529–539. [Google Scholar]
  35. Xia M, Xu Z. Hesitant fuzzy information aggregation in decision making. Int J Approx Reason. 2011;52:395–407. doi: 10.1016/j.ijar.2010.09.002. [DOI] [Google Scholar]
  36. Xu Z. Intuitionistic fuzzy aggregation operators. IEEE Trans Fuzzy Syst. 2007;15(6):1179–1187. doi: 10.1109/TFUZZ.2006.890678. [DOI] [Google Scholar]
  37. Xu Z, Yager RR. Some geometric aggregation operators based on intuitionistic fuzzy sets. Int J Gen Syst. 2006;35(4):417–433. doi: 10.1080/03081070600574353. [DOI] [Google Scholar]
  38. Xu Z, Zhou W. Consensus building with a group of decision makers under the hesitant probabilistic fuzzy environment. Fuzzy Optim Decis Making. 2017;16(4):481–503. doi: 10.1007/s10700-016-9257-5. [DOI] [Google Scholar]
  39. Yager RR. Pythagorean membership grades in multicriteria decision making. IEEE Trans Fuzzy Syst. 2013;22(4):958–965. doi: 10.1109/TFUZZ.2013.2278989. [DOI] [Google Scholar]
  40. Yager RR (2013a) Pythagorean fuzzy subsets. In: Joint IFSA world congress and NAFIPS annual meeting (IFSA/AFIPS). IEEE. pp 57–61
  41. Yu D, Wu Y, Zhou W. Multi-criteria decision making based on Choquet integral under hesitant fuzzy environment. J Comput Inf Syst. 2011;7(12):4506–4513. [Google Scholar]
  42. Zadeh LA. Fuzzy sets. Inf Control. 1965;8(3):338–353. doi: 10.1016/S0019-9958(65)90241-X. [DOI] [Google Scholar]
  43. Zhang Z. Hesitant fuzzy power aggregation operators and their application to multiple attribute group decision making. Inf Sci. 2013;234:150–181. doi: 10.1016/j.ins.2013.01.002. [DOI] [Google Scholar]

Articles from Journal of Ambient Intelligence and Humanized Computing are provided here courtesy of Nature Publishing Group

RESOURCES